Nonclinical factors associated with the treatment of older women with newly diagnosed low‐grade ductal carcinoma in situ
Cancer · 2024
DOI: 10.1002/cncr.35124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Thomas DeLeire und 3 weiteren Autor:innen. Beteiligte Einrichtung: McCourt School of Public Policy, Georgetown University, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Surgeons, Carcinoma, Ductal, Breast. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Ductal carcinoma in situ (DCIS) is the most common form of noninvasive breast cancer and is associated with an excellent prognosis. As a result, there is concern about overdiagnosis and overtreatment of DCIS because most patients with DCIS are treated as though they have invasive breast cancer and undergo either breast‐conserving surgery (BCS)—most commonly followed by radiation therapy (RT)—or mastectomy. Little research to date has focused on nonclinical factors influencing treatments for DCIS.
Methods
Population‐based data were analyzed from five state cancer registries (California, Florida, New Jersey, New York, and Texas) on women aged 65 years and older newly diagnosed with DCIS during the years 2003 to 2014 using a retrospective cohort design and multinominal logistic modeling. The registry records with Medicare enrollment data and fee‐for‐service claims to obtain treatments (BCS alone, BCS with RT, or mastectomy) were merged. Surgeon practice structure was identified through physician surveys and internet searches.
Results
Patients of surgeons employed by cancer centers or health systems were less likely to receive BCS with RT or mastectomy than patients of surgeons in single specialty or multispecialty practices. There also was substantial geographic variation in treatments, with patients in New York, New Jersey, and California being less likely to receive BCS with RT or mastectomy than patients in Texas or Florida.
Conclusions
These findings suggest nonclinical factors including the culture of the practice and/or financial incentives are significantly associated with the types of treatment received for DCIS. Increasing awareness and targeted efforts to educate physicians about DCIS management among older women with low‐grade DCIS could reduce patient harm and yield substantial cost savings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- McCourt School of Public Policy, Georgetown University, Washington, District of Columbia, USA.
- School of Medicine, Georgetown University, Washington, District of Columbia, USA.
ORCID-Profile: Thomas DeLeire, Jean M Mitchell
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
DeLeire, T., Mitchell, J. M., De La Cruz, L., & Isaacs, C. (2024). Nonclinical factors associated with the treatment of older women with newly diagnosed low‐grade ductal carcinoma in situ. Cancer. https://doi.org/10.1002/cncr.35124
Vancouver
DeLeire T, Mitchell JM, De La Cruz L, Isaacs C. Nonclinical factors associated with the treatment of older women with newly diagnosed low‐grade ductal carcinoma in situ. Cancer. 2024. doi:10.1002/cncr.35124
BibTeX
@article{DeLeire2024,
author = {DeLeire, Thomas and Mitchell, Jean M and De La Cruz, Lucy and Isaacs, Claudine},
title = {Nonclinical factors associated with the treatment of older women with newly diagnosed low‐grade ductal carcinoma in situ},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35124}
}
EUVIMED